There is no treatment for monkeypox, but outbreaks can be controlled by infection prevention.Vaccination against smallpox has been proven to be 85% effective in preventing monkeypox.The UK has bought doses of the smallpox vaccine, but it is not clear how many jabs might be given.
Antiviral drugs may also help.
Should I be worried?
Monkeypox “is usually a mild self-limiting illness and most people recover within a few weeks,” the UKHSA said in its statement.
“It is important to emphasise that monkeypox does not spread easily between people and the overall risk to the general public is very low,” said Dr Colin Brown, the agency’s director of clinical and emerging infections.
The patients infected in England contracted the West African clade of the virus, which health officials say is mild compared to the Central African clade and has a case fatality ratio of around 1 per cent.
Although its symptoms are milder than those of smallpox, monkeypox has been shown to cause death in as many as 10 per cent of patients infected with the Congo Basin clade, compared to about 30 per cent for smallpox, according to WHO data.
Mortality is higher among children and young adults, and immunocompromised individuals are especially at risk of severe disease.
Monkeypox during pregnancy may also lead to complications, congenital monkeypox, or stillbirth, the WHO warned on Monday.
"Milder cases of monkeypox may go undetected and represent a risk of person-to-person transmission," it said in a statement.
Treatment and prevention
Monkeypox usually goes away on its own, but an oral antiviral drug called Tecovirimat was approved earlier this year in the European Union to treat smallpox, monkeypox and cowpox and it can limit the spread and severity of the disease.Vaccination against smallpox is believed to be highly effective in preventing monkeypox, but because smallpox was declared eradicated more than 40 years ago, younger populations "no longer benefit from the protection afforded by prior smallpox vaccination programmes," says the WHO.A newer vaccine developed by Bavarian Nordic for the prevention of both smallpox and monkeypox has been approved in the European Union, the United States, and Canada (under the trade names Imvanex, Jynneos and Imvamune), but it's not yet widely available.Common household disinfectants can kill the monkeypox virus, says the CDC.